Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 06/20/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants.

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.

Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones.

Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.

The experience of combined and sequential liver and kidney transplantation from a single living donor in patients with primary hyperoxaluria type 1.

Combined liver-kidney transplantation for primary hyperoxaluria type I in children: Single Center Experience.

Showing 1-6 of 6

Last Updated : 06/20/2022